The Lead Episode 24: A Discussion of Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation-The Lead Episode 24 Speaker Information

The Lead Episode 24 Speaker Information

Pdf Summary

In this discussion, the focus is on catheter ablation in end-stage heart failure patients with atrial fibrillation. The article for discussion is titled "Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation" and was published in the New England Journal of Medicine. The hosts of the discussion are Dr. William H. Sauer from Brigham and Women's Hospital, and the contributors are Dr. Akshay Suvas Desai and Dr. Kolade Muchaili Agboola, also from Brigham and Women's Hospital.<br /><br />The disclosure information reveals that the contributors have received honoraria, speaking fees, and consulting fees from various pharmaceutical and medical device companies. They have also conducted research with companies like Medtronic, Bayer Healthcare Pharmaceuticals, and Novartis.<br /><br />Catheter ablation is a procedure used to treat atrial fibrillation, a common heart rhythm disorder. In this study, the focus is on patients with end-stage heart failure, who often have more severe symptoms and a higher risk of complications. The CASTLE-HTx Investigators conducted the study.<br /><br />The discussion includes the potential benefits and risks associated with catheter ablation in this specific patient population. The contributors share their expertise and insights based on their clinical experience and the available research.<br /><br />Overall, this discussion aims to provide a comprehensive understanding of catheter ablation in end-stage heart failure patients with atrial fibrillation, considering both the potential benefits and risks of the procedure. The contributors bring their knowledge and experiences to shed light on this important topic for medical professionals and researchers in the field.

Keywords

catheter ablation

end-stage heart failure

atrial fibrillation

New England Journal of Medicine

Brigham and Women's Hospital

disclosure information

research

benefits

risks

patient population